alexa Ligand Conformational Analysis Enabling Improved Nrf2 Activators | 62507
ISSN: 2161-0444

Medicinal Chemistry
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

5th International Conference on Medicinal Chemistry & Computer Aided Drug Designing and Drug Delivery
December 05-07, 2016 Phoenix, USA

Thorsten Nowak, Sadia Mohammed, Martin Watson, Emma Blaney, Charles Blundell and Craig Fox
C4X Discovery Ltd, UK
ScientificTracks Abstracts: Med chem
DOI: 10.4172/2161-0444.C1.027
Abstract
In particular, effective anti-inflammatory therapy is required in addition to bronchodilator therapy as disease severity progresses. While oral PDE4 inhibitors are currently used for this purpose and have been shown to be effective on exacerbation rates, their degree of efficacy is disappointing. In this regard, Nrf-2 activators have the potential to be efficacious on exacerbation rate with much a better tolerability profile. However, it has been difficult to create highly potent drug-like non-covalent inhibitors for the key Nrf2/Keap-1 protein-protein interaction (PPI). Nrf2 is a master regulator of the cell’s antioxidant response and its activation leads to a coordinated antioxidant and anti-inflammatory response. Here we present a detailed 3D-structural analysis of a publicly available Nrf2 activator, which functions by blocking the interaction of Nrf2 with its repressor Keap-1. The variety of conformations that the free activator adopts in solution was precisely measured using the NMR methodology of Blundell et al and this data was combined with results from protein X-ray co-crystallography and in-silico docking. The synergistic combination of these techniques provides unique insights into the disruption of this proteinprotein interface, and demonstrates the power of combining ligand-based and structure-based drug design approaches. These data provide clear, immediate and rational strategies for both conventional and conformational design of the ligand to achieve improved potency.
Biography

Thorsten Nowak completed his PhD from the University of Cambridge (UK) in the areas of aldol methodology and natural product synthesis. In 1996, he joined AstraZeneca where he worked on all stages of drug discovery from target to candidate selection in medicinal chemistry as team leader and project manager. His keen interest in new technologies motivated a career move from big pharma to platform technology business in 2012 when he joined C4X Discovery. In his current role, he is responsible for all internal drug discovery projects at C4X Discovery as well as continued development of the technology in the context of application to drug discovery.

Email: [email protected]

image PDF   |   image HTML
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version